Skip to main content

NCT00202865 - Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (CANDLE)

Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (CANDLE)

Data Request Dashboard

Operations

No data requests found. Click here to generate a new one.


CSR Summary

Not Available


Data Specification

Not Yet Available


Annotated CRF

Not Yet Available

Product Info

Generic Name
Infliximab
Product Name
REMICADE®
Therapeutic Area
Muscle, Bone, and Cartilage Diseases
Enrollment
76
Product Class
Antirheumatic agents - biologic response modifiers
Sponsor Protocol Number
P04352
Data Holder
Johnson & Johnson
Condition Studied
Spondylitis, Ankylosing

Supporting Documentation

Clinical Study Report
Study Phase 
3
Additional Information: 

Please note: Individual-participant level data are not available for this trial. However, the full Clinical Study Report can be provided.

Disclaimer

Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.